Skip to main content

Table 1 Patient characteristics (numbers of patients unless stated otherwise)

From: MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer

  Early-stage
(FIGO IA-Ic)
(n = 23)
Advanced-stage
FIGO (IIB-IV)
(n = 74)
Total
(n = 97)
Age (median (min-max)) 59 (24–81) 64 (30–84) 62 (24–84)
Histological subtype
 Low-grade serous 10 14 24
 High-grade serous 0 42 42
 Mucinous 4 4 8
 Endometroid 1 3 4
 Clear cell 6 2 8
 Adenocarcinoma unspecified   7 7
 Mixed 2 2 4
Differentiation
 Low-grade 12 18 30
 High-grade 11 56 67
 CA 125 (median (min-max)) 61 (7–3222) 615 (9–37500) 332 (7–37500)
FIGO stage
 IA-IC 23   23
 IIB   14 14
 III   44 44
 IV   16 16
Debulking (only advanced stage disease)
 Complete   62  
 Incomplete   12  
Overall Survival (months (minimum-maximum)) 64 (28–75) 38 (0–76) 50 (0–76)
Number of deceased patients 4 51 55